Deborah Weitzman
Known title: CEO, Pharmaceutical SegmentCIK: 0001942639
Associated companies
Transaction History
| CAH | ▲ Buy | Grant | 54,823 | $0 | 8/4/2026 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 551 | $117K | 12/1/2025 | View on chart |
| CAH | ▼ Sell | Open Market | 21,367 | $3.2M | 8/20/2025 | View on chart |
| CAH | ▲ Buy | Grant | 10,694 | $0 | 8/15/2025 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 24,128 | $3.6M | 8/15/2025 | View on chart |
| CAH | ▲ Buy | Grant | 39,100 | $0 | 8/12/2025 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 632 | $77K | 12/2/2024 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 2,341 | $253K | 8/16/2024 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 9,918 | $1.1M | 8/15/2024 | View on chart |
| CAH | ▲ Buy | Grant | 13,530 | $0 | 8/15/2024 | View on chart |
| CAH | ▲ Buy | Grant | 13,926 | $0 | 8/13/2024 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 638 | $68K | 12/1/2023 | View on chart |
| CAH | ▲ Buy | Option Exercise | 15,373 | $1.0M | 11/27/2023 | View on chart |
| CAH | ▼ Sell | Open Market | 36,642 | $3.9M | 11/27/2023 | View on chart |
| CAH | ▲ Buy | Option Exercise | 5,990 | $505K | 11/27/2023 | View on chart |
| CAH | ▲ Buy | Option Exercise | 6,279 | $522K | 11/27/2023 | View on chart |
| CAH | ▲ Buy | Option Exercise | 6,712 | $479K | 8/28/2023 | View on chart |
| CAH | ▼ Sell | Open Market | 6,712 | $603K | 8/28/2023 | View on chart |
| CAH | ▲ Buy | Grant | 15,487 | $0 | 8/16/2023 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 10,966 | $1.0M | 8/15/2023 | View on chart |
| CAH | ▲ Buy | Grant | 12,760 | $0 | 8/7/2023 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 380 | $30K | 12/1/2022 | View on chart |